Variant ID | 9140 |
---|---|
Entrez Gene ID | 577 |
Gene | ADGRB3 (GeneCards) |
Location | hg19 6:70159745-70159745
hg38 6:69449853-69449853 |
Disease | Asymptomatic |
Method | HiSeq X Ten |
Mutation(HGVS format) | NC_000006.11:g.70159745 G>A (Genome Assembly: GRCh37) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 171115067 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | 0.0147 |
CADD Raw score (version 1.3) | 1.358646 (Deleterious) |
FATHMM raw prediction score | 0.43199 (Tolerated) |
Deleterious probability by DeFine | 0.0792 (Neutral) |
Entrez Gene ID | 577 (NCBI Gene) |
---|---|
Official Gene Symbol | ADGRB3 (GeneCards) |
Number of variants in ADGRB3 in this database | 111 (view all the variants) |
Full name | adhesion G protein-coupled receptor B3 |
Band | 6q12-q13 |
Other IDs | Vega: OTTHUMG00000014982 OMIM: 602684 HGNC: HGNC:945 Ensembl: ENSG00000135298 |
Other names | BAI3 |
Summary | This p53-target gene encodes a brain-specific angiogenesis inhibitor, a seven-span transmembrane protein, and is thought to be a member of the secretin receptor family. Brain-specific angiogenesis proteins BAI2 and BAI3 are similar to BAI1 in structure, have similar tissue specificities, and may also play a role in angiogenesis. [provided by RefSeq, Jul 2008] |
Individual ID | 29217584.06 (view all the variants in this individual) |
---|---|
Pubmed ID | 29217584 |
Whose mosaic mutation | Normal |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |
Pubmed ID | 29217584 |
---|---|
Title | Aging and neurodegeneration are associated with increased mutations in single human neurons. |
Journal | Science |
Publication date | 2018.02 |
Disease | Cockayne syndrome Xeroderma Pigmentosum |
Number of cases | Male cases: 3; Female cases: 6; cases of unknown sex: 15; |